Sionna Therapeutics, Inc.
SION
$24.39
$0.652.74%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | |||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -- | -- | -- | ||
| Cost of Revenue | -- | -- | -- | ||
| Gross Profit | -- | -- | -- | ||
| SG&A Expenses | 113.24% | 104.68% | 43.44% | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 94.00% | 49.53% | 43.97% | ||
| Operating Income | -94.00% | -49.53% | -43.97% | ||
| Income Before Tax | -111.27% | -39.12% | -33.45% | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -111.27% | -39.12% | -33.45% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -111.27% | -39.12% | -33.45% | ||
| EBIT | -94.00% | -49.53% | -43.97% | ||
| EBITDA | -95.57% | -50.22% | -44.49% | ||
| EPS Basic | 84.87% | 83.87% | 13.82% | ||
| Normalized Basic EPS | 84.87% | 83.88% | 13.82% | ||
| EPS Diluted | 84.87% | 83.87% | 13.82% | ||
| Normalized Diluted EPS | 84.87% | 83.88% | 13.82% | ||
| Average Basic Shares Outstanding | 1,296.20% | 762.78% | 54.85% | ||
| Average Diluted Shares Outstanding | 1,296.20% | 762.78% | 54.85% | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||